RPI Announces Three New Members to the Board of Directors
TROY, NY – Rensselaer Polytechnic Institute has named three dynamic new members to the Rensselaer Board of Trustees. The new members, who will serve 4-year terms beginning January 1, 2022, are: John M. Capek, BS ’83, ME ’84, ME ’85, MBA ’87, Ph.D. ’88; Mary Humiston, MBA ’90; and Roderic “Rod” I. Pettigrew, MS ’73.
“The Board is delighted to welcome these distinguished pioneers to the leadership team,” said Arthur F. Golden, BS ’66, JD and Chairman of the Board. “Their experience, expertise and wisdom will provide crucial guidance as we shape the future of healthcare through engineering and precision medicine.”
“I am delighted that these distinguished individuals have become members of the Board of Directors,” said Dr. Shirley Ann Jackson, President of Rensselaer. “As graduates of the Institute, these leaders each bring unique strengths and important perspectives in engineering, human health and business, and will make important contributions to the university as it continues to address pressing issues. society faces as we approach our 200th anniversary in 2024.”
Dr. Capek is Executive Vice President of Enterprises at Abbott Laboratories. He currently leads Abbott’s venture capital investment organization as well as new ventures including Abbott Electrophysiology. Previously, he served as Executive Vice President, Medical Devices and Senior Vice President, Abbott Vascular, leading Abbott’s global vascular business.
Prior to joining Abbott, Dr. Capek held various leadership positions at Guidant Corporation, including President, Guidant Vascular Intervention, and Vice President and General Manager, Bioabsorbable Vascular Solutions. He also served as vice president and general manager of Guidant Germany and vice president, marketing, Guidant Cardiac Rhythm Management Group. Prior to joining Guidant, Dr. Capek was Head of New Product Technology at Eli Lilly & Company.
He holds a bachelor’s degree in biomedical engineering, a master’s degree in biomedical engineering, a master’s degree in electrical engineering, a doctorate in biomedical engineering, and a master’s degree in business administration, all from Rensselaer Polytechnic Institute.
Mary Humiston is a senior consultant at Accenture. She was Executive Director of Accenture’s CHRO Forum, a collaboration of the world’s top human resource managers. She is also the founder of Modern Career, which offers career coaching, workshops, and a career podcast to help professionals navigate more successfully in an ever-changing world and work environment.
Prior to joining Accenture, Humiston was Director of Human Resources for Rolls-Royce plc., headquartered in London, where she oversaw a workforce of 55,000 people in 30 countries, partnered to lead the transformation of the company and in 2016 established a leadership academy with the University of Oxford. .
Humiston has held various human resources leadership positions in a number of companies and industries, including senior vice president of human resources at Applied Materials, a global leader in semiconductor technology. Prior to joining Applied Materials, she was Vice President of Human Resources at Honeywell Inc. She began her career at General Electric (GE) on the Human Resources Leadership Program and spent seven years in Human Resources and Workforce. corporate audit of GE. She holds a master’s degree in business administration from Rensselaer Polytechnic Institute and a bachelor’s degree in psychology from Siena College. She also studied at Oxford University as an undergraduate.
Roderic I. Pettigrew is the inaugural Dean of the Intercollegiate School of Engineering Medicine at Texas A&M University, in partnership with Houston Methodist Hospital. He previously served as Managing Director of Engineering Health (EnHealth) and Executive Dean of Engineering Medicine (EnMed), also at Texas A&M. Dr. Pettigrew also holds the Robert A. Welch Chair in Medicine at Texas A&M.
An internationally recognized leader in biomedical imaging and bioengineering, Dr. Pettigrew was the founding director of the National Institute for Biomedical Imaging and Bioengineering of the National Institutes of Health (NIH) for 15 years. Prior to his NIH appointment, he joined Emory University School of Medicine as a professor of radiology and medicine (cardiology) and the Georgia Institute of Technology as a professor of bioengineering. He is known for his pioneering work in four-dimensional imaging of the cardiovascular system using magnetic resonance imaging (MRI).
Dr. Pettigrew is a member of the National Academy of Medicine, the National Academy of Engineering (NAE), the National Academy of Inventors, the American Academy of Arts and Sciences, and the National Academy of Indian science. His awards include gold medals from the Academy of Radiology Research and the Radiological Society of North America, the Arthur M. Bueche Award from the NAE, and the Vannevar Bush Award from the National Science Board.
Dr. Pettigrew holds a BS in Physics from Morehouse College, an MS in Nuclear Science and Engineering from Rensselaer Polytechnic Institute, a PhD in Applied Radiation Physics from the Massachusetts Institute of Technology, and an MD by Leonard M. Miller. University of Miami School of Medicine. He completed a nuclear medicine residency at UC-San Diego.